pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 1,486 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
lithium citrate
Lithium Citrate (lithium citrate)
Alzheimer's Disease
Glycogen synthase kinase-3Inositol monophosphatase 1
Medesis Pharma SA
0 catalysts
Phase 2
litoxetine
litoxetine [INN]
Stress Urinary Incontinence
Vaneltix Pharma Inc
0 catalysts
Phase 2
lixadesiran + pixofisiran
lixadesiran [INN] + pixofisiran [INN]
Basal Cell Carcinoma (Basal Cell Epithelioma)
← prev
page 40 of 50
next →
131
Pain89
Neurology1
Sirnaomics Ltd
0 catalysts
Phase 2
lixosicone
lixosicone [INN]
Substance (Drug) Abuse
Aelis Farma SAS
0 catalysts
Phase 2
lonigutamab
lonigutamab [INN]
Graves' Ophthalmopathy
$ALMSALUMIS INC.
0 catalysts
Phase 2
lorigerlimab
Colorectal Cancer
$MGNXMACROGENICS INC
0 catalysts
Phase 2
lucicebtide
Esophageal Cancer
Sapience Therapeutics Inc
0 catalysts
Phase 2
lucinactant
Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress Syn…
Lee's Pharmaceutical Holdings Ltd
0 catalysts
Phase 2
ludotadipep
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
FutureChem Co Ltd
0 catalysts
Phase 2
lufepirsen
Nexagon (lufepirsen [INN])
Persistent Corneal Epithelial Defects
Amber Ophthalmics Inc
0 catalysts
Phase 2
lumacaftor
Subarachnoid Hemorrhage
Cystic fibrosis transmembrane conductance regulator
Qanatpharma AG
0 catalysts
Phase 2
lunbotinib
lunbotinib [INN]
Non-Small Cell Lung Cancer
Ellipses Pharma Ltd
0 catalysts
Phase 2
luvesilocin
luvesilocin [INN]
Post Partum Depression (Maternal Depression / Postnatal Depression)
Reunion Neuroscience Inc
0 catalysts
Phase 2
luvixasertib
luvixasertib [INN]
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
Treadwell Therapeutics Inc
0 catalysts
Phase 2
luvomeran
Cystic Fibrosis
$VERXVertex, Inc.
0 catalysts
Phase 2
luvometinib
luvometinib [INN]
Neurofibromatoses Type I (Von Recklinghausen's Disease)
Shanghai Fosun Pharmaceutical (Group) Co Ltd
0 catalysts
Phase 2
mRNA-3705
Methylmalonic Acidemia
$MRNAModerna, Inc.
0 catalysts
Phase 2
mRNA-3927
Propionic Acidemia
$MRNAModerna, Inc.
0 catalysts
Phase 2
mRNA-4359
Solid Tumor
$MRNAModerna, Inc.
0 catalysts
Phase 2
malaria [strain NF-54] vaccine 2
Malaria
Sanaria Inc
0 catalysts
Phase 2
margetuximab
Margenza (margetuximab-cmkb)
Gastric Cancer
Receptor tyrosine-protein kinase erbB-2
TerSera Therapeutics LLC
0 catalysts
Phase 2
maveropepimut-s
Fallopian Tube Cancer
$BVAXFBioVaxys Technology Corp.
0 catalysts
Phase 2
mavrilimumab
Rheumatoid Arthritis
Granulocyte-macrophage colony-stimulating factor receptor
MedImmune Ltd
0 catalysts
Phase 2
mavrostobart
Solid Tumor
Phanes Therapeutics Inc
0 catalysts
Phase 2
mazindol ER
Quilience (mazindol)
Idiopathic Hypersomnia (IH)
Monoamine transporter
$NCELNewcelX Ltd.
0 catalysts
Phase 2
mebufotenin
mebufotenin [INN]
Treatment Resistant Depression
$ATAIAtaiBeckley Inc.
0 catalysts
Phase 2
mecasermin rinfabate
Bronchopulmonary Dysplasia
Insulin-like growth factor 1 receptor
Chiesi Farmaceutici SpA
0 catalysts
Phase 2
mecbotamab vedotin
Non-Small Cell Lung Cancer
Tyrosine-protein kinase receptor UFOTubulin
$BCABBioAtla, Inc.
0 catalysts
Phase 2
meningococcal (pentavalent) vaccine
MenPenta
Neisseria meningitidis Infections
$SNYSanofi
0 catalysts
Phase 2
meplazumab
Ketantin
Malaria
Jiangsu Pacific Meinuoke Bio-Pharmarceutical Co Ltd
0 catalysts